Cargando…

Efficient simulation of clinical target response surfaces

Simulation of combination therapies is challenging due to computational complexity. Either a simple model is used to simulate the response for many combinations of concentration to generate a response surface but parameter variability and uncertainty are neglected and the concentrations are constant...

Descripción completa

Detalles Bibliográficos
Autores principales: Lill, Daniel, Kümmel, Anne, Mitov, Venelin, Kaschek, Daniel, Gobeau, Nathalie, Schmidt, Henning, Timmer, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007598/
https://www.ncbi.nlm.nih.gov/pubmed/35199969
http://dx.doi.org/10.1002/psp4.12779
_version_ 1784686883536633856
author Lill, Daniel
Kümmel, Anne
Mitov, Venelin
Kaschek, Daniel
Gobeau, Nathalie
Schmidt, Henning
Timmer, Jens
author_facet Lill, Daniel
Kümmel, Anne
Mitov, Venelin
Kaschek, Daniel
Gobeau, Nathalie
Schmidt, Henning
Timmer, Jens
author_sort Lill, Daniel
collection PubMed
description Simulation of combination therapies is challenging due to computational complexity. Either a simple model is used to simulate the response for many combinations of concentration to generate a response surface but parameter variability and uncertainty are neglected and the concentrations are constant—the link to the doses to be administered is difficult to make—or a population pharmacokinetic/pharmacodynamic model is used to predict the response to combination therapy in a clinical trial taking into account the time‐varying concentration profile, interindividual variability (IIV), and parameter uncertainty but simulations are limited to only a few selected doses. We devised new algorithms to efficiently search for the combination doses that achieve a predefined efficacy target while taking into account the IIV and parameter uncertainty. The result of this method is a response surface of confidence levels, indicating for all dose combinations the likelihood of reaching the specified efficacy target. We highlight the importance to simulate across a population rather than focus on an individual. Finally, we provide examples of potential applications, such as informing experimental design.
format Online
Article
Text
id pubmed-9007598
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-90075982022-04-15 Efficient simulation of clinical target response surfaces Lill, Daniel Kümmel, Anne Mitov, Venelin Kaschek, Daniel Gobeau, Nathalie Schmidt, Henning Timmer, Jens CPT Pharmacometrics Syst Pharmacol Research Simulation of combination therapies is challenging due to computational complexity. Either a simple model is used to simulate the response for many combinations of concentration to generate a response surface but parameter variability and uncertainty are neglected and the concentrations are constant—the link to the doses to be administered is difficult to make—or a population pharmacokinetic/pharmacodynamic model is used to predict the response to combination therapy in a clinical trial taking into account the time‐varying concentration profile, interindividual variability (IIV), and parameter uncertainty but simulations are limited to only a few selected doses. We devised new algorithms to efficiently search for the combination doses that achieve a predefined efficacy target while taking into account the IIV and parameter uncertainty. The result of this method is a response surface of confidence levels, indicating for all dose combinations the likelihood of reaching the specified efficacy target. We highlight the importance to simulate across a population rather than focus on an individual. Finally, we provide examples of potential applications, such as informing experimental design. John Wiley and Sons Inc. 2022-03-11 2022-04 /pmc/articles/PMC9007598/ /pubmed/35199969 http://dx.doi.org/10.1002/psp4.12779 Text en © 2022 The Authors. CPT: Pharmacometrics & Systems Pharmacology published by Wiley Periodicals LLC on behalf of the American Society for Clinical Pharmacology and Therapeutics. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Lill, Daniel
Kümmel, Anne
Mitov, Venelin
Kaschek, Daniel
Gobeau, Nathalie
Schmidt, Henning
Timmer, Jens
Efficient simulation of clinical target response surfaces
title Efficient simulation of clinical target response surfaces
title_full Efficient simulation of clinical target response surfaces
title_fullStr Efficient simulation of clinical target response surfaces
title_full_unstemmed Efficient simulation of clinical target response surfaces
title_short Efficient simulation of clinical target response surfaces
title_sort efficient simulation of clinical target response surfaces
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007598/
https://www.ncbi.nlm.nih.gov/pubmed/35199969
http://dx.doi.org/10.1002/psp4.12779
work_keys_str_mv AT lilldaniel efficientsimulationofclinicaltargetresponsesurfaces
AT kummelanne efficientsimulationofclinicaltargetresponsesurfaces
AT mitovvenelin efficientsimulationofclinicaltargetresponsesurfaces
AT kaschekdaniel efficientsimulationofclinicaltargetresponsesurfaces
AT gobeaunathalie efficientsimulationofclinicaltargetresponsesurfaces
AT schmidthenning efficientsimulationofclinicaltargetresponsesurfaces
AT timmerjens efficientsimulationofclinicaltargetresponsesurfaces